• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C2 THERAPEUTICS CRYOBALLOON ABLATION SYSTEM; CRYOSURGICAL UNIT WITH ACCESSORIES, PRODUCT CODE: GEH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C2 THERAPEUTICS CRYOBALLOON ABLATION SYSTEM; CRYOSURGICAL UNIT WITH ACCESSORIES, PRODUCT CODE: GEH Back to Search Results
Model Number FG1012
Device Problems Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Patient Problems Dysphagia/ Odynophagia (1815); Vomiting (2144); Stenosis (2263); Laceration(s) of Esophagus (2398)
Event Date 01/04/2018
Event Type  Injury  
Manufacturer Narrative
Stricture or narrowing of the esophagus is a known and anticipated adverse event after an endoscopic therapy procedure for treatment of barrett's esophagus.This stricture is probably related to the procedure.
 
Event Description
On august 2, 2017, c2 therapeutics was informed of an adverse event.After the initial procedure, a (b)(6) study participant was diagnosed with narrowing of the esophagus (stricture) on (b)(6) 2017.The patient had complained of difficulty swallowing and was vomiting food.The patient was also experiencing abdominal pain; this was not reported as serious.There were no issues noted with the device.An attempt to obtain the actual device and a lot number was unsuccessful as the site did not note the device information.
 
Event Description
C2 therapeutics became aware of esophageal laceration on (b)(6) 2018.- initial report referenced in mdr 3008780134-2017-00012.Serious adverse event type: laceration (non-transmural tear) of the esophagus requiring treatment.The subject was scheduled for a 6-month follow up esophagogastroduodenoscopy (egd) on (b)(6) 2018.He had complained of moderate passage: able to eat some solid foods and identified a 5 on pain scale.During the beginning of the procedure "one moderate benign-appearing, intrinsic stenosis was found 36cm from the incisors".This measured 9 mm (inner diameter) and was traversed after dilation.A through the scope (tts) dilator was used to treat the stenosis.Post dilation a deep laceration was observed; 3 endoclips were placed to close that laceration.No cryotherapy procedure was performed during this follow-up egd.The patient was administered antibiotics and kept nothing by mouth (npo) and was admitted to the hospital ward for observation.The subject was discharged on (b)(6) 2017 12:00 pm.A follow up egd is scheduled for the middle of (b)(6) 2018.
 
Manufacturer Narrative
This is a supplemental/follow-up report for mdr 3008780134 2017 00012 based on additional information provided by the physician.The subject was initially treated with cryoballoon system on (b)(6) 2017.Subject subsequently was treated twice for symptoms related to stricture, on (b)(6) 2017 and (b)(6) 2017.In both instances, symptoms resolved after dilation treatment with a through-the-scope (tts) 15-16.5-18mm balloon dilator.Post cryoballoon ablation, the treating physician reported a stricture that was procedure related.During the 6-month follow up egd a moderate, benign-appearing intrinsic stenosis was observed and dilation was performed using a balloon dilator.Post dilation, a deep laceration was observed.Because the laceration was discovered post dilation, it appears that the laceration occurred as a result of the dilation procedure.It was also reported that the physician did not attempt cryoballoon treatment during this follow up visit, therefore, c2 device was not used and actual device evaluation could not be performed.Per request from fda on 26mar2020, supplemental report was submitted with incorrect report number.This report is being submitted to correct the report number from 3008780134-2018-00002 to 3008780134-2017-00012 note: the following code/s on previous follow-up no longer available.3263-actual device not evaluated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRYOBALLOON ABLATION SYSTEM
Type of Device
CRYOSURGICAL UNIT WITH ACCESSORIES, PRODUCT CODE: GEH
Manufacturer (Section D)
C2 THERAPEUTICS
303 convention way, ste 1
redwood city CA 94063
MDR Report Key6822474
MDR Text Key83726576
Report Number3008780134-2017-00012
Device Sequence Number1
Product Code GEH
Combination Product (y/n)N
PMA/PMN Number
K161202
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberFG1012
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/05/2018
Patient Sequence Number1
Patient Outcome(s) Other;
-
-